Navigation Links
Herley Industries, Inc. First Quarter Earnings Release and Conference Call Notice
Date:12/16/2008

Conference Call Scheduled for Wednesday, December 17, 2008

LANCASTER, Pa., Dec. 16 /PRNewswire-FirstCall/ -- Herley Industries, Inc. (Nasdaq: HRLY) expects to release First Quarter Financial Results after the market closes on Tuesday, December 16, 2008.

A Conference Call has been scheduled for 9:00 a.m. Eastern Time on Wednesday, December 17, 2008. Interested parties may join the conference by dialing: (888) 425-4188 referencing Conference ID # 77420347.

Replay of the conference call is scheduled to begin on December 17, 2008, two hours after completion of the call, and end on December 24 at 11:59 p.m. Eastern Time. To listen to the replay dial: 1 (800) 642-1687 (U.S.) or 1 (706) 645-9291 (International), andConference ID # 77420347.

This conference call will be broadcast live over the Internet and can be accessed by interested parties through URL: http://www.videonewswire.com/event.asp?id=54095.

To listen to the live call, please go to the Web site at least fifteen minutes prior to the start of the call to register, download, and install any necessary audio software. For those who are not available to listen to the live broadcast, a replay will be available shortly after the call on the site.

Herley Industries, Inc. is a leader in the design, development and manufacture of microwave technology solutions for the defense, aerospace and medical industries worldwide. Based in Lancaster, PA, Herley has eight manufacturing locations and approximately 1000 employees. Additional information about the company can be found on the Internet at www.herley.com .

Safe Harbor Statement - Except for
'/>"/>

SOURCE Herley Industries, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Herley Reports 4th Quarter and Year-End Results
2. Herley Industries, Inc. Receives a $5 Million Award from EDO for Electronic Components for IEDs
3. Herley Industries Announces the Passing of Its Former President
4. Herley Industries, Inc. Second Quarter Earnings Release and Conference Call Notice
5. Herley Reports Second Quarter Results
6. Herley Awarded $1 Million in Awards for Integrated Microwave Assemblies for U.S. Military Aircraft
7. Herley Announces Settlement Agreement with U.S. Government
8. Herley Reports Third Quarter Results
9. Herley Industries, Inc. Engages Jefferies Quarterdeck to Explore Strategic Alternatives
10. Herley New England Receives Additional $1.3 Million Contract Award from Lockheed Martin for the Multi-Mission Helicopter
11. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ench . , An innovative treatment for HIV pat... researchers has passed its first clinical trial w...herapy customized for each individual patient, and... Institute of the MUHC in collaboration with Dr. R...vaccine made for the individual patient an "haute...
(Date:11/25/2009)...ess for patients with liver lesions, researchers f...ws) -- Adding the drug cetuximab to neoadjuvant ch... successful surgery in colorectal cancer patients ...arch suggests. , , Tumors spread to other part...olorectal cancer. Most commonly, the cancer spread...
(Date:11/25/2009)...pport for recent enforcement actions against rogue...ion of Chain Drug Stores (NACDS) submitted a lette...letter expresses the Association’s concern a...gn, that are engaged in a pattern of illegal activ...escription medications. , ...
(Date:11/25/2009)...-Reportlinker.comannouncesthatanewmarketresearchre...rAnti-ageingFoods(2ndEdition) ,, http://www....ng-Foods-(2nd-Edition ).html ,, Theglobalfuncti...owthoutstrippingthatofconventionalfoods,andproduct...ive,sstrictapproachtohealthclaimshoweverwillclearl...
(Date:11/25/2009)...Flexibility,AllowingCompanytoAccessCapitalatitsDis...stCall/-LabopharmInc.(TSX:DDS;NASDAQ: DDSS )todaya...agreement(SEDA)withYAGlobalMasterSPVLtd.,afundmana...ment,YAhascommittedtoprovideupto$25millionofcapita...hroughthepurchaseofnewlyissuedLabopharmcommonshare...
Breaking Medicine News(10 mins):Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:NACDS Supports FDA Enforcement Against Rogue Internet Pharmacy Websites 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 3Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 4Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 5Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 6Health News:Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement 2Health News:Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement 3
...lysis, the use of dialysis filters coated with vit...mmon problem of anemia, reports a paper presented ...nual Meeting and Scientific Exposition in San Dieg... were switched from "regular" dialysis filters to ...
...retakers sent letters to city, state and federal a...osal procedures were not stringent //enough in tre...iseases such as mad cow and chronic wasting diseas...e at length. The eight-person panel investigated t...
...tion about the risks of nanotechnology in society,...owerful potential according //to 14 top internatio...ovember 16th issue of the journal Nature. The pape...ach its full promise. The paper's lead author...
...worship-with 1,000 pyres began Friday here to ward...Amid chanting of Vedic hymns by Hindu priests from...on their heads, the ritual was performed with the ...ngha, was to ward off dengue, malaria and other di...
...nalities may face risk of developing coronary hear... led by Edward Suarez at Duke University studied 2...during the Vietnam War. The men got heart c...on of health magazine WebMD. Each of these ...
...s information available on the internet is causing...g to a health watchdog. // The NHS Quality Imp... available on the web have been increasing the dan...alth watch dog for doctors in Scotland on the best...
Other Medicine News:Health News:Vitamin E-Coated Dialysis Filters Help Fight Anemia in Hemodialysis Patients 2Health News:Complaints Against US Federal lab Over-ruled by Panel 2Health News:Fear of Possible Harm Hinder Nanotech Development 2Health News:Internet Health Advice Causing More Harm than Good 2
(Date:11/24/2009)...irstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS...perJaffrayHealthcareConferenceonTuesday,December1,...gheldatTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Pr...eanoverviewofAnadysanditsclinicaldevelopmentprogra...willbesimultaneouslywebcastandcanbeaccessedontheIn...
(Date:11/24/2009)...wire/--ZargisMedicalCorp.,asubsidiaryofSpeedusCorp...search(NYSE: SI ),todayannouncedthatitsZargisCardi...fCBS, TheEarlyShow duringasegmentinwhichMarkJannot...inningproductsfromthepublication,s2009"BestofWhat,...elevisionmorningnewstalkshowbroadcastbyCBSfromNewY...
(Date:11/24/2009)...-USNewswire/--America,spharmaceuticalresearchandbi...estotreatorpreventHIV/AIDSandrelatedconditions,acc...ResearchandManufacturersofAmerica(PhRMA).December1...renesscampaignthatoriginatedatthe1988WorldSummitof..., "Wearegreatlyencouragedbythesecriticallyimport...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 1Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 1Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 4ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 1ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 2ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 3
...wswire/ -- Mersana, a,cancer therapeutics company,...es with its lead product candidate, XMT-1001, will...eting of the,American Association of Cancer Resear...s, CA. Full text of the abstracts can be,viewed on...f=,"http://www.aacr.org/">http://www.AACR.org . , ...
...e Oncology Compounds at the,American Association f...l., April 13, 2007 /PRNewswire-FirstCall/ -- For,d...hat target,cancer. Researchers now know that cance...y require new blood vessels to deliver oxygen,and ...,(proliferation), they travel throughout the body ...
Other Medicine Technology:Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 2Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 3Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 4
...nsfers depurinated DNA and RNA from agarose gels t...es ,Increases speed and efficiency of transfer by ...of an integrated system allowing electrophoresis, ... hours, versus 29 hours required for conventional ...
...nsfers depurinated DNA and RNA from agarose gels t...es ,Increases speed and efficiency of transfer by ...of an integrated system allowing electrophoresis, ... hours, versus 29 hours required for conventional ...
PosiBlot 30-30 Pads
Liquid Trap
Medicine Products: